MNOV Insider Trading Activity and SEC Form 4 Filings
MNOV insider trading summary
Over the past 12 months, insiders at Medicinova Inc (MNOV) reported 2 sales worth $3.5M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $3.5M.
Latest MNOV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 25, 2026 | 3D Opportunity Master Fund | Insider | Sell | $1.7M (640,000 @ $2.70) |
| Sep 25, 2026 | 3D Investment Partners Pte. Ltd. | Insider | Sell | $1.7M (640,000 @ $2.70) |
| Nov 28, 2022 | Hideki Nagao | Director | Sell | $15K (6,754 @ $2.25) |
| Nov 22, 2022 | Hideki Nagao | Director | Sell | $464 (218 @ $2.13) |
| Nov 21, 2022 | Hideki Nagao | Director | Sell | $12K (5,365 @ $2.18) |
| Nov 17, 2022 | Hideki Nagao | Director | Sell | $674 (309 @ $2.18) |
| Mar 11, 2021 | Hideki Nagao | Director | Sell | $17K (2,354 @ $7.40) |
| Sep 15, 2020 | Hideki Nagao | Director | Sell | $6K (1,000 @ $5.78) |
| Mar 13, 2020 | Kazuko Matsuda | Chief Medical Officer | Buy | $7K (2,000 @ $3.62) |
| Mar 12, 2020 | Yuichi Iwaki | President and CEO | Buy | $62K (20,000 @ $3.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.